These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4258203)

  • 1. Human platelet clumping by bovine fibrinogen during its degradation.
    De Gaetano G; Donati MB; Vermylen J
    Scand J Haematol Suppl; 1971; 13():281-3. PubMed ID: 4258203
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of human platelet aggregation by plasmin digests of human and bovine fibrinogen preparations: role of contaminating factor VIII-related material.
    Culasso DE; Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1974 Aug; 44(2):169-75. PubMed ID: 4277539
    [No Abstract]   [Full Text] [Related]  

  • 3. Human platelet clumping by bovine fibrinogen.
    Donati MB; De Gaetano G; Vermylen J
    Acta Univ Carol Med Monogr; 1972; 53():21-6. PubMed ID: 4275440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of fibrinolysis and fibrinogenolysis products on thrombocyte adhesiveness].
    Levin GIa; Fisher SI; Mishukova GN
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):33-4. PubMed ID: 4273647
    [No Abstract]   [Full Text] [Related]  

  • 5. Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation.
    Larrieu MJ
    Scand J Haematol Suppl; 1971; 13():273-9. PubMed ID: 5290691
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism by which bovine fibrinogen induces the release and availability reaction of human blood platelets.
    Kubisz P; Suranová J
    Thromb Diath Haemorrh; 1973 May; 29(2):416-33. PubMed ID: 4202691
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen degradation products and fibrinogen to fibrin conversion.
    Arnesen H
    Scand J Haematol Suppl; 1971; 13():245-52. PubMed ID: 5290685
    [No Abstract]   [Full Text] [Related]  

  • 9. Bovine fibrinogen-induced platelet factor 3 and acid phosphatase availability in human platelets.
    Kubiaz P; Suranová J
    Scand J Haematol; 1973; 10(3):189-96. PubMed ID: 4203486
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of human platelet aggregation by plasmin digests of human factor VIII.
    Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1973 Nov; 42(5):749-51. PubMed ID: 4270477
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 12. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS.
    KOWALSKI E; KOPEC M; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Jan; 10():406-23. PubMed ID: 14113380
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirement of human plasmin for streptokinase activation of bovine plasminogen.
    Reddy KN; Kline DL
    Thromb Res; 1975 Jun; 6(6):481-8. PubMed ID: 239462
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of bile salts on some coagulation components and related enzymes.
    Engel AM; Alexander B
    Thromb Diath Haemorrh; 1972 Jul; 27(3):594-609. PubMed ID: 4268053
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmin inhibition of thrombin-induced platelet aggregation.
    Miller JL; Katz AJ; Feinstein MB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmic degradation of fibrinogen.
    Wallén P
    Scand J Haematol Suppl; 1971; 13():3-14. PubMed ID: 4258207
    [No Abstract]   [Full Text] [Related]  

  • 18. THERMOSTABLE ANTICOAGULANT FROM THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Br J Haematol; 1965 May; 11():331-41. PubMed ID: 14282070
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutual interaction between platelets and fibrinogen and its derivatives.
    Stachurska J; Wegrzynowicz Z; Latallo ZS; Kopec M
    Acta Univ Carol Med Monogr; 1972; 53():17-20. PubMed ID: 4275439
    [No Abstract]   [Full Text] [Related]  

  • 20. Human fibrinopeptides as antithrombins.
    Gorman JJ; Castaldi PA
    Thromb Diath Haemorrh; 1973 May; 29(2):347-52. PubMed ID: 4762258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.